Authors

  1. Nollino, Laura MD
  2. Marcon, Maria Lisa PgDip
  3. Kiwanuka, Edward MD, PhD
  4. Merlotto-Cazziola, Michela RN
  5. Sambataro, Maria MD
  6. Sambado, Luisa PhD
  7. Trevisiol, Enrica PHARMD
  8. Scantamburlo, Antonella PgDip
  9. Mauri, Alessandra PSYCH
  10. Busato, Enrico MD
  11. Pirolo, Roberta PHARMD
  12. Boaretto, Massimo MD
  13. Turolla, Licia MD
  14. Faronato, Pietro Paolo MD
  15. Cadamuro-Morgante, Marco MD
  16. Migot, Roberta PSYCH
  17. Paccagnella, Agostino MD

Abstract

Background: Gestational diabetes mellitus (GDM) is an impaired glucose tolerance with onset or first recognition during pregnancy. The purpose of this study is to evaluate the clinical outcomes of a blood glucose monitoring protocol implemented by nurses and dietitians in a diabetes team to the previously established protocol of direct monitoring of GDM patients by a diabetologist.

 

Methods: Two groups of patients were formed: The first group was based on a traditional protocol (P1: 230 patients) with patients' blood glucose constantly checked by a diabetologist. In the second structured group (P2: 220 patients) patients were referred to a diabetologist only if they required insulin therapy.

 

Results: The number of medical visits (P2: 1.28 +/- 0.70 vs P1: 3.27 +/- 1.44; P < .001) and the percentage of patients with hypoglycemia (P2: 6.8% vs P1: 15.2%; P < .006) were found to be lower in group P2 than in group P1. In both groups, a direct relationship was found between a parental history of diabetes and the risk of GDM (odds ratio [OR]: P1 = 2.2 [1.17-4.12]; P2 = 2.5 [1.26-5.12]). In group P1, it was observed that hyperweight gain in patients who were already overweight before becoming pregnant significantly increased the risk of macrosomia (OR: 3.11 [1.39-25.7]), whereas this was not detected in patients in group P2. In group P2, a correlation was found between macrosomia and insulin therapy (OR: 0.066 vs 0.34). In group P1 and group P2, a correlation was observed between insulin therapy and a family history of diabetes (OR: 2.20 vs 2.27), and a body mass index of greater than 30 kg/m2 in group P2 (OR: 3.0 vs 1.47).

 

Conclusions: The data we collected show that creating a structured protocol for GDM management reduces the number of medical visits required by patients without increasing the risk of hypoglycemia, macrosomia, or hyperweight gain during pregnancy.